OBSEVA SA (OBSV) Stock Price, Quote, News and Overview
NASDAQ:OBSV - Nasdaq - CH0346177709 - Common Stock - Currency: USD
OBSV Quote, Performance and Key Statistics
0.1018
-0.02 (-15.52%)
The current stock price of OBSV is 0.1018 USD. In the past month the price decreased by -41.8%. In the past year, price decreased by -92.4%.
OBSV Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About OBSV
Company Profile
ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women's reproductive health and pregnancy. The company is headquartered in Plan-Les-Ouates, Geneve and currently employs 51 full-time employees. The company went IPO on 2018-07-13. The firm develops oral compounds to treat women’s reproductive health conditions from conception to birth. Its pipeline includes three product candidates: Linzagolix (OBE2109), an oral gonadotropin-releasing hormone (GnRH) receptor antagonist intended for the treatment of endometriosis and uterine fibroids; Nolasiban (OBE001), an oral oxytocin receptor antagonist, with the potential to inhibit uterine contractions at the time of embryo transfer, thereby enhancing embryo implantation during assisted reproductive technologies (ART), and OBE022, an oral and selective prostaglandin F2 alpha (PGF2a) receptor antagonist designed to control preterm labor.
Company Info
OBSEVA SA
Chemin des Aulx 12
Plan-les-Ouates GENEVE 1228 CH
CEO: Brian O'Callaghan
Employees: 51
Company Website: http://www.obseva.com/
Phone: 41225521558.0
OBSEVA SA / OBSV FAQ
What is the stock price of OBSEVA SA today?
The current stock price of OBSV is 0.1018 USD. The price decreased by -15.52% in the last trading session.
What is the ticker symbol for OBSEVA SA stock?
The exchange symbol of OBSEVA SA is OBSV and it is listed on the Nasdaq exchange.
On which exchange is OBSV stock listed?
OBSV stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for OBSEVA SA stock?
7 analysts have analysed OBSV and the average price target is 12.24 USD. This implies a price increase of 11923.58% is expected in the next year compared to the current price of 0.1018. Check the OBSEVA SA stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is OBSEVA SA worth?
OBSEVA SA (OBSV) has a market capitalization of 8.60M USD. This makes OBSV a Nano Cap stock.
How many employees does OBSEVA SA have?
OBSEVA SA (OBSV) currently has 51 employees.
What are the support and resistance levels for OBSEVA SA (OBSV) stock?
OBSEVA SA (OBSV) has a resistance level at 0.11. Check the full technical report for a detailed analysis of OBSV support and resistance levels.
Is OBSEVA SA (OBSV) expected to grow?
The Revenue of OBSEVA SA (OBSV) is expected to decline by -33.03% in the next year. Check the estimates tab for more information on the OBSV EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy OBSEVA SA (OBSV) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of OBSV, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of OBSV, evaluating the profitability, health, valuation and growth aspects
- OBSEVA SA (OBSV) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- OBSEVA SA (OBSV) Sales and EPS estimates to see what analysts future expectations are.
- OBSEVA SA (OBSV) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- OBSEVA SA (OBSV) Insider and Institutional Ownership to learn about the owners and their transactions.
- OBSEVA SA (OBSV) Stock Chart to make your own analysis
- OBSEVA SA (OBSV) Latest news and press-releases to stay up to date.
Does OBSEVA SA (OBSV) stock pay dividends?
OBSV does not pay a dividend.
When does OBSEVA SA (OBSV) report earnings?
OBSEVA SA (OBSV) will report earnings on 2023-08-15.
What is the Price/Earnings (PE) ratio of OBSEVA SA (OBSV)?
OBSEVA SA (OBSV) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.79).
OBSV Technical Analysis
OBSV Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to OBSV. Both the profitability and financial health of OBSV have multiple concerns.
OBSV Financial Highlights
Over the last trailing twelve months OBSV reported a non-GAAP Earnings per Share(EPS) of -0.79. The EPS increased by 6.94% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
OBSV Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 46% to OBSV. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 12.85% and a revenue growth -33.03% for OBSV